BAC
Bank of America Corporation
BAC has the edge over RNR overall, supported by stronger modeled upside and lower modeled downside.
RNR
RenaissanceRe Holdings Ltd.
RNR trails on the overall score without a compensating advantage in the available component scores.
BAC Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| N/A | |
| N/A |
BAC's revenue and profitability are currently healthy. Free cash flow and net leverage aren't meaningful measures for financial services companies like BAC.
RNR Fundamentals
| Metric | Status |
|---|---|
| Weak | |
| Strong | |
| N/A | |
| N/A |
RNR's profitability is currently strong, but its revenue is weak. Free cash flow and net leverage aren't meaningful measures for financial services companies like RNR.
BAC PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 9.4x | $39.50 | -22% |
| Forward | 10x | $50.51 | — |
| Current | 12x | $50.51 | — |
| Fair | 13x | $53.81 | +6.5% |
| Expensive | 15x | $62.23 | +23% |
Historical ranges are pointers, not guarantees.
BAC has the edge over RNR in the historical PE scenario, which offers more potential upside but is not a forecast.
RNR PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 5x | $171 | -52% |
| Fair | 7.4x | $256 | -28% |
| Forward | 8.4x | $355 | — |
| Current | 10x | $355 | — |
| Expensive | 15x | $500 | +41% |
Historical ranges are pointers, not guarantees.
RNR's PE is in its fair range at 10x. On analysts' estimates for next year's earnings, today's price would be 8.4x.
BAC Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Growth | |
| Growth | |
| Strongly improving | |
| Limited | |
| Moderate |
BAC has the edge over RNR on the outlook, with more favorable earnings and revenue expectations.
RNR Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Stable | |
| Decline | |
| Strongly improving | |
| Limited | |
| Low |
Analysts expect RNR's profitability to improve, but its revenue to decline. However, they disagree widely on these estimates.
BAC Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $4.92 | +17% |
| Q3 2026 | $4.19 | +14% |
| Q2 2026 | $4.34 | +27% |
| Q1 2026 | $4.02 | +20% |
| Q4 2025 | $3.81 | +19% |
| Q3 2025 | $3.66 | +33% |
| Q2 2025 | $3.41 | +20% |
| Q1 2025 | $3.35 | +16% |
| Q4 2024 | $3.21 | +4.2% |
BAC has the edge over RNR on earnings, with more consistent year-over-year improvement.
RNR Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $42.22 | +22% |
| Q3 2026 | $34.47 | -4.5% |
| Q2 2026 | $57.88 | +47% |
| Q1 2026 | $59.33 | +88% |
| Q4 2025 | $56.03 | +59% |
| Q3 2025 | $36.11 | -49% |
| Q2 2025 | $39.33 | -24% |
| Q1 2025 | $31.54 | -32% |
| Q4 2024 | $35.21 | -33% |
RNR's earnings per share have fallen from their peak: $34.47 over the past year, against $70.44 in late 2024.
BAC Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $30B | +6.7% |
| Q2 2026 | $31.6B | +19% |
| Q1 2026 | $30.3B | +11% |
| Q4 2025 | $31.2B | +23% |
| Q3 2025 | $28.1B | +11% |
| Q2 2025 | $26.5B | +4.3% |
| Q1 2025 | $27.4B | +6% |
| Q4 2024 | $25.3B | +15% |
BAC has the edge over RNR on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 30% | -3.7 points |
| Q2 2026 | 37% | +7.6 points |
| Q1 2026 | 34% | +4.7 points |
| Q4 2025 | 40% | +12 points |
| Q3 2025 | 34% | +4.8 points |
| Q2 2025 | 29% | -0.7 points |
| Q1 2025 | 30% | +1.5 points |
| Q4 2024 | 28% | +14 points |
BAC has the edge over RNR on profitability, with a higher operating margin.
RNR Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $1.7B | -47% |
| Q2 2026 | $2.8B | -14% |
| Q1 2026 | $2.2B | -37% |
| Q4 2025 | $3B | +30% |
| Q3 2025 | $3.2B | -20% |
| Q2 2025 | $3.2B | +13% |
| Q1 2025 | $3.5B | +34% |
| Q4 2024 | $2.3B | -29% |
RNR's revenue has slid since its 2024 peak: $1.7B last quarter, down 47% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -1.9% | -48 points |
| Q2 2026 | 40% | -1.4 points |
| Q1 2026 | 25% | +27 points |
| Q4 2025 | 43% | +46 points |
| Q3 2025 | 46% | +2.6 points |
| Q2 2025 | 42% | +17 points |
| Q1 2025 | -2% | -26 points |
| Q4 2024 | -3.6% | -48 points |
RNR's operating margin was −1.9% last quarter, down 48 points from the same quarter a year ago.
BAC Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$6.5B | -114% |
| Q2 2026 | $29B | +$38.2B |
| Q1 2026 | $41.8B | +$44B |
| Q4 2025 | -$22.9B | -189% |
| Q3 2025 | $46.9B | +$84.2B |
| Q2 2025 | -$9.1B | -150% |
| Q1 2025 | -$2.2B | +$13.4B |
| Q4 2024 | $25.9B | -21% |
BAC's free cash flow was $41.4B over the past year, down 33% from the year before. Free cash flow isn't a meaningful measure for financial services companies like BAC.
RNR Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $794.5M | -50% |
| Q2 2026 | $852.4M | -42% |
| Q1 2026 | $687.6M | +336% |
| Q4 2025 | $483M | -38% |
| Q3 2025 | $1.6B | +6.2% |
| Q2 2025 | $1.5B | +21% |
| Q1 2025 | $157.8M | -77% |
| Q4 2024 | $778.9M | +52% |
RNR's free cash flow was $2.8B over the past year, down 29% from the year before. Free cash flow isn't a meaningful measure for financial services companies like RNR.
BAC Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -1% | -72M shares |
| 1 year | -5.3% | -405M shares |
| 3 years | -11% | -854M shares |
| 5 years | -15% | -1.3B shares |
| Available history | -24% | -2.2B shares |
BAC has 7.2B diluted shares, down 5.3% from a year ago, with $25.6B in buybacks over the past year.
| Quarter | Spent |
|---|---|
| Q3 2026 | $6B |
| Q2 2026 | $6B |
| Q1 2026 | $7.2B |
| Q4 2025 | $6.3B |
| Q3 2025 | $5.3B |
| Q2 2025 | $5.3B |
| Q1 2025 | $4.5B |
| Q4 2024 | $3.5B |
BAC spent $25.6B buying back its own shares over the past year, up 37% from the year before.
RNR Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -3% | -1.3M shares |
| 1 year | -12% | -5.7M shares |
| 3 years | -20% | -10.1M shares |
| 5 years | -13% | -5.9M shares |
| Available history | -7.5% | -3.3M shares |
RNR has the edge over BAC on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $310.1M |
| Q2 2026 | $350.5M |
| Q1 2026 | $352M |
| Q4 2025 | $660M |
| Q3 2025 | $208.3M |
| Q2 2025 | $373.6M |
| Q1 2025 | $357.7M |
| Q4 2024 | $451.6M |
RNR spent $1.7B buying back its own shares over the past year, up 20% from the year before.
BAC Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 6.4x | High |
| Q2 2026 | 6.7x | High |
| Q1 2026 | 7.1x | High |
| Q4 2025 | 7.7x | High |
| Q3 2025 | 8.3x | High |
| Q2 2025 | 8.8x | High |
| Q1 2025 | 8.6x | High |
| Q4 2024 | 9.0x | High |
BAC's net debt is about 6.4 years of its operating earnings (EBITDA), down from 8.3 years a year ago. Net leverage isn't a meaningful measure for financial services companies like BAC.
RNR Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 0.4x | Very low |
| Q2 2026 | 0.2x | Very low |
| Q1 2026 | 0.2x | Very low |
| Q4 2025 | 0.2x | Very low |
| Q3 2025 | 0.2x | Very low |
| Q2 2025 | 0.3x | Very low |
| Q1 2025 | 0.4x | Very low |
| Q4 2024 | 0.1x | Very low |
RNR has the edge over BAC on leverage, with a lower net debt burden relative to earnings.
BAC Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 37.1 | Neutral |
| Stochastic | 4.9 | Oversold |
BAC's weekly RSI is 37 (neutral) and its Stochastic is 5 (oversold).
RNR Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 67.5 | Neutral |
| Stochastic | 66.9 | Neutral |
RNR's weekly RSI is 67 (neutral) and its Stochastic is 67 (neutral).
BAC PE vs Financial Services Sector
| Metric | BAC | Sector median | Relative |
|---|---|---|---|
| PE | 12x | 13x | 7.5% below |
| PE % | 40 | 63 | 23 pts below |
BAC is trading at 12x earnings, in line with the Financial Services sector's median of 13x.
RNR PE vs Financial Services Sector
| Metric | RNR | Sector median | Relative |
|---|---|---|---|
| PE | 10x | 13x | 21% below |
| PE % | 62 | 63 | 1 pt below |
RNR has the edge over BAC on valuation relative to its sector.
BAC Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $52.1 | 3% below |
| 20 week MA | $57.8 | 13% below |
| 50 week MA | $54.7 | 7.7% below |
| 100 week MA | $50.5 | 0% below |
| 200 week MA | $42.5 | 19% above |
BAC has fallen below most of its moving averages, though it's still 19% above its 200-week average.
RNR Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $340.9 | 4% above |
| 20 week MA | $331.1 | 7.1% above |
| 50 week MA | $307.5 | 15% above |
| 100 week MA | $276.5 | 28% above |
| 200 week MA | $248.0 | 43% above |
RNR has the edge over BAC on trend strength, trading above more of its moving averages.
BAC Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $35.4 | $30.0 | -15% |
| 2021 | $30.0 | $44.4 | +48% |
| 2022 | $44.4 | $32.5 | -27% |
| 2023 | $32.5 | $33.7 | +3.7% |
| 2024 | $33.7 | $44.3 | +32% |
| 2025 | $44.3 | $56.2 | +27% |
| 2026 YTD | $56.2 | $50.5 | -10% |
BAC has finished higher in four of the last six years. It's down 10% so far in 2026.
RNR Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $195.7 | $161.4 | -18% |
| 2021 | $161.4 | $167.7 | +3.9% |
| 2022 | $167.7 | $186.9 | +11% |
| 2023 | $186.9 | $196.0 | +4.9% |
| 2024 | $196.0 | $250.6 | +28% |
| 2025 | $250.6 | $281.4 | +12% |
| 2026 YTD | $281.4 | $354.7 | +26% |
RNR has the edge over BAC on returns for 2026, with the stronger performance.